Nicholas W Baxter's Net Worth
$1.58 Million
Who is Nicholas W Baxter?
Nicholas W Baxter has an estimated net worth of $1.58 Million. This is based on reported shares across multiple companies, which include PACIFIC ALLIANCE VENTURES LTD, and Lexaria Bioscience Corp..
SEC CIK
Nicholas W Baxter's CIK is 0001312326
Past Insider Trading and Trends
2014 was Nicholas W Baxter's most active year for acquiring shares with 6 total transactions. Nicholas W Baxter's most active month to acquire stocks was the month of March. 2011 was Nicholas W Baxter's most active year for disposing of shares, totalling 2 transactions. Nicholas W Baxter's most active month to dispose stocks was the month of March. 2006 saw Nicholas W Baxter paying a total of $1,500,000.00 for 500,000 shares, this is the most they've acquired in one year. In 2020 Nicholas W Baxter cashed out on 150,000 shares for a total of $148,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PACIFIC ALLIANCE VENTURES LTD No price found
President and CEONicholas W Baxter owns 7,573,364 units of Common Stock. Nicholas W Baxter used to own units in Common Shares but no longer holds any shares there.acquired a total of 9,073,364 shares in PACIFIC ALLIANCE VENTURES LTD at a cost of $408,341.00, Nicholas also disposed a total of 10,573,364 shares of PACIFIC ALLIANCE VENTURES LTD equalling to $299,651.25.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.57M |
$0.02 | -$144,651.25 |
0
|
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2 - Apr 4
| |||
Form 4
| +194.30% | 5M |
$0.05 | $250,000.00 | 7.57M |
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14 - Jun 1
| |||
Form 4
| -27.98% | -1.00M |
$0.06 | -$55,000.00 | 2.57M |
Mar 11
| |||
Form 4
| +232.91% | 2.5M |
$0.05 | $125,000.00 | 3.57M |
Nov 19
| |||
Form 4
| -65.08% | -2.00M |
$0.05 | -$100,000.00 | 1.07M |
May 26
| |||
Form 4
| +2.45% | 73.36K |
$0.25 | $18,341.00 | 3.07M |
Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
| +100.00% | 1.5M |
$0.01 | $15,000.00 | 3M |
Feb 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lexaria Bioscience Corp. (LEXX) Snapshot price: $3.26
InvestorNicholas W Baxter owns 330,000 units of Common Shares which is worth $1,075,800.00 and 200,000 units of Common Stock which is worth $652,000.00. From 2022 to 2024 Nicholas W Baxter acquired a total of 330,000 shares in Lexaria Bioscience Corp. at a cost of $35,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| +50.00% | 110K |
$0.10 | $11,000.00 | 330K |
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +10.00% | 20K |
—
|
—
| 220K |
Jul 11 - Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4
| +733.33% | 176K |
$0.12 | $21,120.00 | 200K |
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
∞
| 24K |
$0.12 | $2,880.00 | 24K |
Jul 8 - Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||